Also trades as: 0J9P.L (LSE) · $vol 0M

$116.60

+3.29 (+2.90%)

Weekly Expected Move ±4.1%

$106 $111 $116 $120 $125

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 46 · $23.6B mcap · 201M float · 0.853% daily turnover · Short 79% of daily vol

Credit Risk of going bust: lower than 96% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Incyte Corporation would be worth roughly what it owes.
Total debt $38.3M against a stock market value of $23.63B.
Distance to default 21.19 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $19.1M (short-term plus half of long-term), stock volatility 33.6%; Altman Z'' 10.50. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

58.0 / 100

NoneWeakNarrowWide

Primary source: Network Effects · ROIC: 82.1% · 5Y Avg: -56.2%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. INCY has a Narrow competitive edge (58.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 82.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$104

Low

$135

Avg Target

$157

High

Based on 19 analysts since Jul 28, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 23Hold: 20Sell: 1Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$135.37

Analysts19

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-27	Oppenheimer	—	$120	$152	+32	+34.1%	$113.31
2026-10-16	Raymond James	—	Initiated	$152	—	+34.2%	$113.27
2026-10-14	Truist Financial	Srikripa Devarakonda	$105	$115	+10	+3.2%	$111.44
2026-10-08	RBC Capital	—	$109	$114	+5	+2.0%	$111.78
2026-10-05	UBS	Ashwani Verma	$113	$127	+14	+12.4%	$113.03
2026-10-05	Stifel Nicolaus	Stephen Willey	$145	$157	+12	+36.2%	$115.30
2026-09-28	H.C. Wainwright	Mitchell Kapoor	$150	$152	+2	+22.7%	$123.89
2026-08-20	Canaccord Genuity	—	Initiated	$152	—	+18.3%	$128.47
2026-08-17	Piper Sandler	Allison Bratzel	$110	$130	+20	+8.2%	$120.16
2026-08-13	Bernstein	—	$99	$104	+5	-13.9%	$120.77
2026-08-03	Leerink Partners	Andrew Berens	$63	$155	+92	+29.7%	$119.52
2026-07-29	RBC Capital	Brian Abrahams	$99	$109	+10	-14.0%	$126.69
2026-07-29	BMO Capital	—	$112	$130	+18	+0.9%	$128.83
2026-07-29	Guggenheim	Whitney Ljem	$92	$150	+58	+15.4%	$129.93
2026-07-29	Morgan Stanley	—	$104	$119	+15	-8.4%	$129.93
2026-07-29	H.C. Wainwright	—	$140	$150	+10	+15.4%	$129.93
2026-07-29	Barclays	—	$134	$139	+5	+7.0%	$129.93
2026-07-28	Stifel Nicolaus	Stephen Willey	$123	$145	+22	+11.5%	$130.08
2026-07-28	Oppenheimer	—	$107	$120	+13	-7.7%	$130.08
2026-07-23	Morgan Stanley	—	$102	$104	+2	-10.4%	$116.12
2026-07-14	Barclays	—	$117	$134	+17	+17.3%	$114.23
2026-07-13	BMO Capital	—	$94	$112	+18	-2.6%	$115.04
2026-07-07	RBC Capital	—	$84	$99	+15	-14.4%	$115.62
2026-06-26	UBS	—	$68	$113	+45	+5.1%	$107.53
2026-06-22	Truist Financial	—	$103	$105	+2	+1.7%	$103.21
2026-06-22	BMO Capital	Evan David Seigerman	$48	$94	+46	-4.3%	$98.22
2026-06-10	H.C. Wainwright	Mitchell Kapoor	$135	$140	+5	+35.6%	$103.23
2026-06-09	Stifel Nicolaus	Stephen Willey	$120	$123	+3	+19.3%	$103.07
2026-06-08	Oppenheimer	Jay Olson	$90	$107	+17	+6.3%	$100.64
2026-05-21	Bernstein	—	Initiated	$99	—	+1.6%	$97.41
2026-04-29	Oppenheimer	—	$82	$90	+8	-7.9%	$97.74
2026-02-18	Barclays	—	$116	$117	+1	+15.7%	$101.16
2026-02-11	Morgan Stanley	—	$92	$102	+10	+3.6%	$98.45
2026-02-11	Stifel Nicolaus	Stephen Willey	$119	$120	+1	+19.9%	$100.05
2026-02-06	Piper Sandler	Allison Bratzel	$102	$110	+8	+7.0%	$102.76
2026-02-05	H.C. Wainwright	—	Initiated	$135	—	+31.6%	$102.60
2026-02-04	Barclays	—	$115	$116	+1	+14.9%	$100.92
2026-01-20	Wells Fargo	—	$116	$107	-9	+0.7%	$106.21
2026-01-08	Goldman Sachs	—	$60	$90	+30	-18.6%	$110.57
2026-01-05	Stifel Nicolaus	Stephen Willey	Initiated	$119	—	+16.9%	$101.79
2025-12-24	Truist Financial	Srikripa Devarakonda	$93	$103	+10	+2.1%	$100.91
2025-12-08	Morgan Stanley	—	$76	$92	+16	-4.6%	$96.47
2025-12-08	Wells Fargo	Derek Archila	$97	$116	+19	+13.1%	$102.52
2025-12-08	Mizuho Securities	Salim Syed	Initiated	$121	—	+18.0%	$102.52
2025-11-24	Barclays	—	$101	$115	+14	+12.7%	$102.06
2025-11-04	Piper Sandler	Allison Bratzel	Initiated	$102	—	-0.3%	$102.35
2025-10-29	Truist Financial	—	Initiated	$93	—	+2.9%	$90.35
2025-10-29	RBC Capital	—	$67	$84	+17	-8.3%	$91.65
2025-10-29	Wells Fargo	Derek Archila	$75	$97	+22	+5.4%	$92.02
2025-10-29	Barclays	Peter Lawson	Initiated	$101	—	+10.2%	$91.65

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A+

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. INCY receives an overall rating of A+. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5), D/E (4/5). Areas of concern: P/B (2/5).

Rating Change History

Date	From	To
2026-10-12	A	A+
2026-08-14	A+	A
2026-07-29	B	A+
2026-07-28	A+	B
2026-07-01	A	A+
2026-05-18	A+	A
2026-05-06	A	A+
2026-04-28	B	A
2026-04-28	A	B
2026-03-16	A+	A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 91 Grade A+

Profitability

100

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. INCY scores highest in Safety (100/100) and lowest in Value (67/100). An overall grade of A+ places INCY among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

11.76

Safe Zone

Piotroski F-Score

8/9

✓ ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓

Beneish M-Score

-2.45

Unlikely Manipulator

Ohlson O-Score

-13.29

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AAA

Score: 97.0/100

Trend: Stable

Earnings Quality

75/100

OCF/NI: 1.23x

Accruals: -5.4%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. INCY scores 11.76, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. INCY scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. INCY's score of -2.45 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. INCY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. INCY receives an estimated rating of AAA (score: 97.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). INCY's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

14.34x

PEG

0.18x

P/S

4.06x

P/B

3.68x

P/FCF

12.29x

P/OCF

11.92x

EV/EBITDA

9.24x

EV/Revenue

3.28x

EV/EBIT

9.70x

EV/FCF

9.95x

Earnings Yield

6.83%

FCF Yield

8.14%

Shareholder Yield

0.03%

Graham Number

$72.86

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 14.3x earnings, INCY trades at a reasonable valuation. An earnings yield of 6.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $72.86 per share, 60% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.820

NI / EBT

Interest Burden

0.999

EBT / EBIT

EBIT Margin

0.338

EBIT / Rev

Asset Turnover

0.850

Rev / Assets

Equity Multiplier

1.302

Assets / Equity

ROE

30.7%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. INCY's ROE of 30.7% is driven by Asset Turnover (0.850), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$298.14

Price/Value

0.38x

Margin of Safety

61.98%

Premium

-61.98%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with INCY's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. INCY actually compounded EPS at 68.3% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. INCY trades at a -62% premium to its adjusted intrinsic value of $298.14, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 14.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$116.60

Median 1Y

$116.46

5th Pctile

$69.41

95th Pctile

$195.65

Ann. Volatility

31.8%

Analyst Target

$135.37

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
William J. Meury Chief Executive Officer	$647,260	$27,509,657	$32,085,952
Mohamed Issa Head utive Vice President and Head of U.S. Commercial	$690,411	$7,870,118	$10,592,782
Pablo J. Cagnoni President and Global Head of Research and Development	$966,516	$4,952,378	$8,838,961
Hervé Hoppenot Former President and Chief Executive Officer	$1,392,499	$1,971,975	$6,380,525
Steven H. Stein Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$835,067	$3,466,675	$6,304,172
Christiana Stamoulis Financial ecutive Vice President and Chief Financial Officer	$520,839	$3,136,468	$4,936,550
Thomas Tray President, dent, Chief Accounting Officer and Principal Financial Officer	$358,189	$305,897	$990,368

CEO Pay Ratio

66:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $32,085,952

Avg Employee Cost (SGA/emp): $483,898

Employees: 2,844

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

2,844

+8.7% YoY

Revenue / Employee

$1,807,750

Rev: $5,141,242,000

Profit / Employee

$452,409

NI: $1,286,650,000

SGA / Employee

$483,898

Avg labor cost proxy

R&D / Employee

$697,456

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	19.3%	29.7%	28.3%	26.9%	23.8%	8.4%	7.8%	8.3%	9.3%	12.5%	15.1%	2.5%	0.8%	0.8%	0.5%	24.3%	30.4%	29.9%	31.1%	30.7%	30.67%
ROA	14.2%	22.3%	21.4%	20.5%	18.0%	6.3%	6.0%	6.4%	7.1%	9.5%	11.5%	1.8%	0.6%	0.5%	0.3%	16.6%	21.0%	20.7%	21.9%	23.5%	23.55%
ROIC	65.2%	72.3%	77.9%	80.7%	74.7%	32.9%	22.9%	21.4%	24.5%	29.7%	33.0%	0.6%	-0.1%	0.6%	1.1%	38.3%	53.9%	63.2%	75.2%	82.1%	82.07%
ROCE	17.9%	14.0%	13.8%	14.4%	12.7%	11.4%	10.7%	11.0%	12.3%	15.1%	17.8%	10.6%	7.9%	8.4%	7.9%	27.8%	31.9%	30.6%	30.4%	30.0%	30.02%
Gross Margin	94.0%	93.8%	92.7%	93.2%	92.0%	92.2%	91.3%	91.3%	91.8%	91.5%	91.2%	91.1%	91.0%	91.1%	91.5%	92.1%	92.8%	92.0%	91.8%	93.7%	93.73%
Operating Margin	30.4%	13.9%	17.4%	28.6%	14.4%	10.1%	3.7%	21.1%	23.4%	20.3%	10.3%	-45.7%	14.9%	25.2%	20.6%	25.6%	32.5%	25.5%	25.5%	41.7%	41.69%
Net Margin	22.4%	65.3%	5.2%	17.7%	13.7%	3.1%	2.7%	21.3%	18.6%	19.8%	19.2%	-42.6%	9.4%	17.1%	15.0%	33.3%	31.1%	19.9%	23.8%	35.0%	34.98%
EBITDA Margin	27.6%	15.7%	12.0%	27.1%	20.2%	10.7%	8.8%	31.3%	27.8%	29.0%	29.3%	-35.2%	15.8%	28.6%	24.4%	47.8%	37.1%	27.5%	28.9%	46.5%	46.51%
FCF Margin	18.7%	19.0%	19.6%	20.0%	21.3%	26.3%	16.2%	19.9%	15.7%	12.1%	21.0%	-3.6%	0.4%	5.5%	6.5%	20.6%	24.9%	26.3%	27.1%	33.0%	33.00%
OCF Margin	25.5%	25.1%	24.4%	22.9%	24.1%	28.6%	18.7%	22.2%	17.5%	13.4%	21.8%	-1.6%	2.5%	7.9%	8.7%	21.9%	26.0%	27.5%	28.3%	34.0%	34.02%
ROE 3Y Avg	snapshot only																				16.51%
ROE 5Y Avg	snapshot only																				16.08%
ROA 3Y Avg	snapshot only																				12.51%
ROIC Economic	snapshot only																				24.19%
Cash ROA	snapshot only																				25.15%
Cash ROIC	snapshot only																				1.07%
CROIC	snapshot only																				1.04%
NOPAT Margin	snapshot only																				26.05%
Pretax Margin	snapshot only																				33.81%
R&D / Revenue	snapshot only																				36.96%
SGA / Revenue	snapshot only																				24.05%
SBC / Revenue	snapshot only																				3.23%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	28.59	17.18	18.98	17.98	17.05	53.01	50.26	38.33	30.74	23.76	17.37	135.93	398.53	418.09	564.21	15.54	14.37	15.72	13.60	14.64	14.342
P/S Ratio	5.25	5.46	5.68	5.12	4.49	5.32	4.70	4.00	3.62	3.84	3.44	3.43	3.18	3.22	2.72	2.95	3.55	3.93	3.63	4.06	4.061
P/B Ratio	4.85	4.32	4.58	4.16	3.53	4.13	3.65	2.96	2.65	2.74	2.40	4.41	4.08	3.96	3.27	3.24	3.67	3.91	3.51	3.72	3.683
P/FCF	28.13	28.66	29.07	25.55	21.02	20.24	29.07	20.13	23.09	31.62	16.37	-94.79	770.44	57.98	41.55	14.31	14.27	14.93	13.42	12.29	12.290
P/OCF	20.62	21.74	23.32	22.35	18.64	18.62	25.14	17.99	20.66	28.60	15.77	—	127.10	40.66	31.37	13.50	13.65	14.31	12.83	11.92	11.923
EV/EBITDA	19.29	22.20	23.97	20.61	18.88	24.78	22.67	16.78	13.22	11.51	8.25	26.64	30.72	28.23	23.68	8.23	8.44	9.50	8.28	9.24	9.239
EV/Revenue	4.48	4.68	4.88	4.31	3.60	4.38	3.81	3.04	2.66	2.86	2.42	3.04	2.75	2.72	2.18	2.43	2.95	3.25	2.89	3.28	3.283
EV/EBIT	21.04	24.44	26.50	22.65	21.01	27.95	25.80	19.00	14.83	12.64	8.94	33.21	40.53	36.13	30.38	8.82	8.92	10.03	8.72	9.70	9.700
EV/FCF	24.00	24.61	24.96	21.52	16.89	16.66	23.59	15.28	16.94	23.56	11.55	-84.17	666.99	48.99	33.36	11.80	11.86	12.34	10.67	9.95	9.949
Earnings Yield	3.5%	5.8%	5.3%	5.6%	5.9%	1.9%	2.0%	2.6%	3.3%	4.2%	5.8%	0.7%	0.3%	0.2%	0.2%	6.4%	7.0%	6.4%	7.4%	6.8%	6.83%
FCF Yield	3.6%	3.5%	3.4%	3.9%	4.8%	4.9%	3.4%	5.0%	4.3%	3.2%	6.1%	-1.1%	0.1%	1.7%	2.4%	7.0%	7.0%	6.7%	7.5%	8.1%	8.14%
PEG Ratio	snapshot only																				0.178
Price/Tangible Book	snapshot only																				3.864
EV/OCF	snapshot only																				9.651
EV/Gross Profit	snapshot only																				3.545
Acquirers Multiple	snapshot only																				10.330
Shareholder Yield	snapshot only																				0.03%
Graham Number	snapshot only																				$72.86

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	3.94	3.65	3.71	3.91	3.80	3.54	3.95	3.81	3.91	3.75	3.47	1.92	1.87	1.97	2.04	2.85	3.20	3.32	3.68	4.66	4.663
Quick Ratio	3.91	3.62	3.67	3.85	3.75	3.50	3.91	3.78	3.86	3.69	3.43	1.84	1.82	1.94	2.00	2.78	3.13	3.25	3.60	4.58	4.577
Debt/Equity	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.006
Net Debt/Equity	-0.71	-0.61	-0.65	-0.66	-0.69	-0.73	-0.69	-0.71	-0.71	-0.70	-0.71	-0.49	-0.55	-0.61	-0.64	-0.57	-0.62	-0.68	-0.72	-0.71	-0.709
Debt/Assets	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.005
Debt/EBITDA	0.06	0.07	0.07	0.06	0.07	0.07	0.07	0.06	0.05	0.04	0.03	0.09	0.10	0.11	0.11	0.03	0.02	0.04	0.02	0.02	0.019
Net Debt/EBITDA	-3.31	-3.66	-3.94	-3.86	-4.62	-5.33	-5.27	-5.32	-4.80	-3.93	-3.45	-3.36	-4.76	-5.18	-5.81	-1.76	-1.72	-1.99	-2.13	-2.17	-2.175
Interest Coverage	391.48	299.97	257.46	247.92	207.66	199.47	208.92	230.71	267.72	328.01	406.46	140.67	103.76	139.87	126.36	516.92	702.21	686.52	760.03	847.54	847.542
Equity Multiplier	1.33	1.31	1.31	1.30	1.30	1.34	1.30	1.31	1.30	1.31	1.32	1.56	1.58	1.58	1.57	1.40	1.36	1.35	1.32	1.24	1.241
Cash Ratio	snapshot only																				3.457
Debt Service Coverage	snapshot only																				889.832
Cash to Debt	snapshot only																				118.529
FCF to Debt	snapshot only																				50.186
Defensive Interval	snapshot only																				583.6 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.78	0.70	0.71	0.72	0.69	0.63	0.64	0.61	0.61	0.59	0.58	0.71	0.72	0.69	0.69	0.87	0.85	0.83	0.82	0.85	0.850
Inventory Turnover	9.29	8.45	7.79	6.12	6.99	7.25	7.08	6.45	5.85	6.00	6.16	4.86	5.62	6.20	6.11	4.27	5.06	5.07	4.68	4.38	4.384
Receivables Turnover	6.67	5.44	6.49	5.92	5.87	5.38	5.85	5.32	5.66	5.32	5.50	5.60	5.76	5.31	5.63	5.80	5.82	5.48	5.72	5.91	5.914
Payables Turnover	1.50	1.38	1.71	1.38	1.69	1.13	2.60	1.66	1.99	1.63	2.93	2.18	2.25	2.46	2.17	2.02	2.22	1.99	1.98	1.75	1.748
DSO	55	67	56	62	62	68	62	69	64	69	66	65	63	69	65	63	63	67	64	62	61.7 days
DIO	39	43	47	60	52	50	52	57	62	61	59	75	65	59	60	86	72	72	78	83	83.3 days
DPO	243	264	213	265	216	324	141	219	183	224	125	167	162	148	168	181	164	183	184	209	208.8 days
Cash Conversion Cycle	-149	-154	-110	-144	-101	-206	-27	-94	-56	-95	1	-27	-34	-21	-44	-32	-29	-45	-42	-64	-63.8 days
Fixed Asset Turnover	snapshot only																				7.917
Operating Cycle	snapshot only																				145.0 days
Cash Velocity	snapshot only																				1.283
Capital Intensity	snapshot only																				1.353

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	18.6%	12.0%	15.2%	22.1%	14.3%	13.7%	11.4%	5.8%	8.4%	8.9%	8.6%	9.8%	12.9%	14.8%	17.1%	18.9%	18.1%	21.2%	21.5%	26.9%	26.93%
Net Income	2.6%	4.2%	95.0%	1.8%	63.9%	-64.1%	-65.2%	-61.2%	-51.5%	75.4%	1.3%	-73.5%	-92.4%	-94.5%	-97.1%	8.0%	35.6%	38.4%	66.3%	85.1%	85.15%
EPS	2.6%	4.2%	94.1%	1.8%	62.5%	-64.5%	-65.6%	-61.6%	-51.9%	74.4%	1.3%	-72.5%	-91.2%	-93.7%	-96.7%	8.8%	34.6%	37.0%	63.5%	76.7%	76.72%
FCF	3.0%	2.8%	7.1%	47.8%	30.8%	56.9%	-7.9%	4.9%	-20.4%	-49.7%	41.0%	-1.2%	-97.0%	-47.6%	-63.5%	7.8%	70.2%	4.8%	4.0%	1.0%	1.03%
EBITDA	4.1%	4.5%	6.5%	50.4%	-6.0%	-4.8%	-8.0%	-8.5%	14.1%	53.3%	89.6%	-30.6%	-49.7%	-55.6%	-63.2%	2.1%	3.6%	3.3%	3.6%	52.6%	52.57%
Op. Income	3.5%	4.0%	16.1%	62.3%	-8.6%	-6.0%	-22.9%	-41.4%	-13.8%	8.7%	42.1%	-92.4%	-1.0%	-87.7%	-71.0%	28.5%	105.9%	15.9%	6.1%	86.0%	85.97%
OCF Growth	snapshot only																				97.40%
Asset Growth	snapshot only																				35.24%
Equity Growth	snapshot only																				52.11%
Debt Growth	snapshot only																				-9.76%
Shares Change	snapshot only																				4.77%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	17.5%	16.6%	16.0%	18.3%	16.5%	16.3%	15.9%	13.7%	13.7%	11.5%	11.7%	12.3%	11.8%	12.4%	12.3%	11.4%	13.1%	14.8%	15.6%	18.3%	18.32%
Revenue 5Y	23.3%	22.0%	20.5%	20.5%	18.6%	17.2%	17.7%	15.2%	15.0%	14.5%	13.5%	14.0%	14.1%	14.5%	14.6%	13.9%	14.4%	14.0%	14.7%	16.4%	16.42%
EPS 3Y	—	1.0%	53.1%	44.3%	28.1%	-9.5%	—	—	—	—	15.0%	-33.5%	-59.0%	-66.2%	-70.5%	1.2%	14.7%	60.7%	68.9%	68.3%	68.31%
EPS 5Y	25.4%	51.6%	—	—	—	—	—	—	—	39.1%	23.0%	-20.5%	-38.3%	-39.5%	—	—	—	—	26.3%	38.5%	38.51%
Net Income 3Y	—	1.1%	54.5%	45.6%	29.3%	-8.7%	—	—	—	—	15.9%	-33.9%	-60.7%	-67.5%	-71.6%	-2.7%	10.7%	55.7%	64.0%	63.9%	63.86%
Net Income 5Y	28.8%	55.5%	—	—	—	—	—	—	—	40.4%	24.1%	-20.5%	-39.6%	-40.8%	—	—	—	—	24.5%	36.7%	36.71%
EBITDA 3Y	—	54.2%	26.1%	23.2%	9.2%	3.4%	—	—	—	—	22.9%	-1.5%	-18.6%	-13.5%	-13.8%	25.0%	38.3%	43.2%	47.5%	48.2%	48.19%
EBITDA 5Y	24.5%	26.4%	—	—	—	—	—	—	—	39.9%	28.4%	3.5%	-5.7%	-5.6%	—	—	—	—	25.7%	35.0%	34.97%
Gross Profit 3Y	17.7%	16.9%	16.0%	18.4%	16.4%	16.0%	15.5%	13.0%	12.9%	10.5%	10.7%	11.4%	10.8%	11.3%	11.4%	10.6%	12.6%	14.7%	15.6%	18.7%	18.71%
Gross Profit 5Y	22.9%	21.9%	20.6%	20.8%	18.8%	17.1%	17.6%	14.9%	14.6%	14.0%	13.1%	13.5%	13.6%	13.9%	14.1%	13.4%	14.0%	13.6%	14.2%	16.1%	16.15%
Op. Income 3Y	—	60.1%	29.9%	34.4%	14.9%	12.4%	—	—	—	—	8.4%	-58.3%	—	-49.9%	-31.8%	9.6%	26.5%	31.2%	42.9%	61.0%	61.04%
Op. Income 5Y	31.2%	31.8%	—	—	—	—	—	—	—	33.2%	19.2%	-35.9%	—	-28.3%	—	—	—	—	21.2%	31.8%	31.78%
FCF 3Y	82.3%	29.3%	15.8%	11.8%	6.5%	12.1%	—	—	—	—	11.6%	—	-68.6%	-25.5%	-22.0%	12.5%	19.0%	14.9%	37.3%	40.1%	40.15%
FCF 5Y	26.3%	25.2%	—	68.6%	—	—	—	—	44.6%	11.3%	15.1%	—	-50.9%	-18.0%	—	—	—	—	20.6%	33.7%	33.68%
OCF 3Y	65.6%	30.6%	17.2%	8.7%	6.5%	10.9%	—	—	—	—	2.4%	—	-48.4%	-23.5%	-20.4%	9.7%	16.0%	13.4%	32.7%	36.4%	36.35%
OCF 5Y	21.5%	19.7%	86.6%	41.8%	54.6%	—	44.9%	1.1%	31.1%	8.1%	11.7%	—	-31.2%	-13.9%	—	—	—	—	14.7%	24.3%	24.25%
Assets 3Y	18.6%	23.1%	22.4%	21.7%	19.7%	19.5%	28.2%	24.6%	24.5%	24.0%	24.9%	6.1%	6.1%	3.3%	4.4%	3.1%	4.7%	6.0%	8.2%	8.2%	8.24%
Assets 5Y	22.1%	24.7%	25.8%	26.5%	18.3%	20.5%	20.2%	21.0%	20.4%	20.7%	21.0%	9.6%	9.3%	9.7%	15.9%	12.6%	13.9%	14.3%	14.9%	15.1%	15.06%
Equity 3Y	20.4%	25.1%	22.8%	22.0%	20.4%	18.9%	32.1%	26.5%	27.3%	25.7%	25.5%	0.7%	0.2%	-2.9%	-1.7%	0.7%	3.2%	5.7%	7.6%	10.2%	10.20%
Book Value 3Y	19.3%	24.0%	21.7%	20.9%	19.2%	17.8%	30.3%	25.5%	25.9%	24.8%	24.5%	1.3%	4.6%	0.9%	2.2%	4.7%	7.0%	9.1%	10.7%	13.2%	13.19%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	1.00	1.00	0.99	0.99	1.00	0.99	1.00	0.98	1.00	1.00	1.00	0.98	1.00	1.00	0.99	0.97	0.98	0.95	0.94	0.92	0.919
Earnings Stability	0.09	0.27	0.52	0.60	0.51	0.31	0.38	0.40	0.36	0.18	0.35	0.03	0.01	0.00	0.06	0.24	0.30	0.25	0.07	0.32	0.324
Margin Stability	0.99	1.00	1.00	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.989
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.50	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.50	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.000
FCF Positive Streak	0	0	1	1	1	1	1	1	1	1	1	0	1	1	1	0	1	1	1	1	0
Earnings Persistence	0.20	0.20	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	—	—	0.36	0.05	0.52	0.06	0.03	0.12	0.31	0.45	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.40	0.403
ROE Trend	0.16	0.22	0.25	0.21	0.19	0.01	-0.14	-0.10	-0.10	-0.05	-0.02	-0.12	-0.14	-0.09	-0.10	0.15	0.21	0.19	0.19	0.13	0.134
Gross Margin Trend	0.00	0.00	-0.00	-0.00	-0.01	-0.01	-0.01	-0.02	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.00	0.00	0.01	0.01	0.01	0.012
FCF Margin Trend	0.10	0.10	0.14	0.14	0.17	0.23	-0.04	0.02	-0.04	-0.11	0.03	-0.24	-0.18	-0.14	-0.12	0.13	0.17	0.18	0.13	0.24	0.245
Sustainable Growth Rate	19.3%	29.7%	28.3%	26.9%	23.8%	8.4%	7.8%	8.3%	9.3%	12.5%	15.1%	2.5%	0.8%	0.8%	0.5%	24.3%	30.4%	29.9%	31.1%	30.7%	30.67%
Internal Growth Rate	16.6%	28.8%	27.2%	25.8%	22.0%	6.8%	6.4%	6.8%	7.7%	10.5%	13.0%	1.8%	0.6%	0.5%	0.3%	19.9%	26.5%	26.2%	28.0%	30.8%	30.80%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.39	0.79	0.81	0.80	0.92	2.85	2.00	2.13	1.49	0.83	1.10	-0.63	3.14	10.28	17.99	1.15	1.05	1.10	1.06	1.23	1.228
FCF/OCF	0.73	0.76	0.80	0.87	0.89	0.92	0.86	0.89	0.89	0.90	0.96	2.28	0.16	0.70	0.75	0.94	0.96	0.96	0.96	0.97	0.970
FCF/Net Income	snapshot only																				1.191
OCF/EBITDA	snapshot only																				0.957
CapEx/Revenue	6.8%	6.1%	4.8%	2.9%	2.7%	2.3%	2.5%	2.4%	1.8%	1.3%	0.8%	2.0%	2.1%	2.4%	2.1%	1.3%	1.1%	1.1%	1.2%	1.0%	1.02%
CapEx/Depreciation	snapshot only																				0.603
Accruals Ratio	-0.06	0.05	0.04	0.04	0.02	-0.12	-0.06	-0.07	-0.03	0.02	-0.01	0.03	-0.01	-0.05	-0.06	-0.03	-0.01	-0.02	-0.01	-0.05	-0.054
Sloan Accruals	snapshot only																				0.342
Cash Flow Adequacy	snapshot only																				33.420
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.6%	1.6%	1.6%	1.3%	6.0%	4.2%	3.4%	20.9%	61.7%	61.5%	94.3%	2.2%	1.6%	1.5%	1.8%	0.4%	0.43%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.2%	0.2%	15.3%	15.5%	14.7%	16.7%	0.1%	0.1%	0.1%	0.1%	0.0%	0.03%
Net Buyback Yield	-0.2%	-0.4%	-0.3%	-0.4%	-0.5%	-0.3%	-0.3%	-0.2%	-0.1%	0.0%	0.1%	15.3%	15.4%	0.0%	-0.0%	-14.8%	-12.0%	-1.0%	-1.5%	-1.6%	-1.57%
Total Shareholder Return	-0.2%	-0.4%	-0.3%	-0.4%	-0.5%	-0.3%	-0.3%	-0.2%	-0.1%	0.0%	0.1%	15.3%	15.4%	0.0%	-0.0%	-14.8%	-12.0%	-1.0%	-1.5%	-1.6%	-1.57%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.86	1.66	1.63	1.50	1.54	0.64	0.64	0.66	0.66	0.72	0.73	0.28	0.12	0.10	0.07	0.69	0.75	0.77	0.81	0.82	0.820
Interest Burden (EBT/EBIT)	1.00	1.00	1.00	1.00	1.00	0.99	1.00	1.00	1.00	1.00	1.00	0.99	0.99	0.99	0.99	1.00	1.00	1.00	1.00	1.00	0.999
EBIT Margin	0.21	0.19	0.18	0.19	0.17	0.16	0.15	0.16	0.18	0.23	0.27	0.09	0.07	0.08	0.07	0.28	0.33	0.32	0.33	0.34	0.338
Asset Turnover	0.78	0.70	0.71	0.72	0.69	0.63	0.64	0.61	0.61	0.59	0.58	0.71	0.72	0.69	0.69	0.87	0.85	0.83	0.82	0.85	0.850
Equity Multiplier	1.36	1.33	1.32	1.31	1.32	1.32	1.30	1.31	1.30	1.32	1.31	1.40	1.41	1.42	1.42	1.46	1.45	1.44	1.42	1.30	1.302

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$2.41	$4.27	$4.18	$4.23	$3.91	$1.52	$1.44	$1.62	$1.88	$2.64	$3.28	$0.45	$0.17	$0.17	$0.11	$4.38	$5.90	$6.28	$6.92	$7.74	$7.74
Book Value/Share	$14.17	$16.98	$17.33	$18.26	$18.85	$19.44	$19.78	$21.01	$21.80	$22.95	$23.74	$13.74	$16.19	$17.46	$18.50	$20.99	$23.09	$25.24	$26.84	$30.47	$31.66
Tangible Book/Share	$12.76	$15.60	$15.98	$16.94	$17.56	$18.17	$18.47	$19.72	$20.55	$21.72	$22.54	$12.50	$14.79	$16.10	$17.18	$19.57	$21.73	$24.01	$25.67	$29.34	$29.34
Revenue/Share	$13.11	$13.45	$13.97	$14.85	$14.86	$15.10	$15.38	$15.57	$15.96	$16.34	$16.58	$17.68	$20.81	$21.48	$22.27	$23.07	$23.89	$25.11	$25.92	$27.95	$29.04
FCF/Share	$2.45	$2.56	$2.73	$2.97	$3.17	$3.97	$2.49	$3.09	$2.50	$1.99	$3.48	$-0.64	$0.09	$1.19	$1.46	$4.76	$5.94	$6.62	$7.01	$9.22	$9.58
OCF/Share	$3.34	$3.38	$3.40	$3.40	$3.58	$4.31	$2.88	$3.46	$2.80	$2.20	$3.61	$-0.28	$0.52	$1.70	$1.93	$5.05	$6.21	$6.90	$7.33	$9.51	$9.88
Cash/Share	$10.28	$10.58	$11.41	$12.17	$13.28	$14.41	$13.80	$15.17	$15.55	$16.17	$16.95	$6.96	$9.06	$10.93	$12.15	$12.19	$14.55	$17.49	$19.42	$21.78	$22.64
EBITDA/Share	$3.04	$2.84	$2.85	$3.10	$2.84	$2.67	$2.59	$2.82	$3.21	$4.07	$4.87	$2.02	$1.86	$2.07	$2.05	$6.82	$8.35	$8.60	$9.05	$9.93	$9.93
Debt/Share	$0.20	$0.20	$0.20	$0.19	$0.19	$0.18	$0.18	$0.18	$0.17	$0.17	$0.16	$0.17	$0.19	$0.22	$0.22	$0.21	$0.20	$0.34	$0.16	$0.18	$0.18
Net Debt/Share	$-10.08	$-10.38	$-11.21	$-11.98	$-13.09	$-14.22	$-13.62	$-15.00	$-15.38	$-16.00	$-16.78	$-6.79	$-8.88	$-10.71	$-11.94	$-11.97	$-14.34	$-17.15	$-19.25	$-21.60	$-21.60

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	11.761
Altman Z-Prime	snapshot only																				22.360
Piotroski F-Score	8	4	4	5	4	5	6	4	6	6	5	3	5	5	6	9	8	7	8	8	8
Beneish M-Score	-2.42	-1.89	-1.80	-1.74	-2.10	-2.99	-2.69	-2.78	-2.46	-2.15	-2.20	-2.09	-2.28	-2.56	-2.67	-2.47	-2.42	-2.44	-2.37	-2.45	-2.453
Ohlson O-Score	snapshot only																				-13.292
ROIC (Greenblatt)	snapshot only																				35.54%
Net-Net WC	snapshot only																				$22.05
EVA	snapshot only																				$1331133759.34

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AAA
Credit Score	96.99	96.92	96.91	97.18	97.16	97.51	96.95	97.19	97.00	96.92	96.78	87.49	95.09	97.08	97.00	96.99	96.67	96.90	96.86	96.98	96.982
Credit Grade	snapshot only																				1
Credit Trend	snapshot only																				-0.010
Implied Spread (bps)	snapshot only																				50.000
Industry Credit Rank	snapshot only																				96
Sector Credit Rank	snapshot only																				92

INCY NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet